Literature DB >> 9527919

Development of a chimeric sindbis virus with enhanced per Os infection of Aedes aegypti.

R C Seabaugh1, K E Olson, S Higgs, J O Carlson, B J Beaty.   

Abstract

The TE/3'2J double subgenomic Sindbis (dsSIN) viruses have been used to stably express genes in Aedes aegypti nerve and salivary gland tissues. However, because these viruses inefficiently infect Ae. aegypti when administered by the per os route, TE/3'2J viruses must be intrathoracically inoculated into the mosquitoes to infect these tissues. A Malaysian Sindbis (SIN) virus isolate (MRE16) does efficiently infect Ae. aegypti midgut tissues after ingestion, and approximately 95% of these mosquitoes also develop disseminated infections within 14 days. We have sequenced the entire 26S RNA of MRE16 virus and have developed a chimeric SIN cDNA infectious clone, designated MRE1001, which contains sequence elements of TE/3'2J and MRE16 virus. MRE1001 virus efficiently infects midgut cells, and greater than 90% of infected mosquitoes develop disseminated infections after 14 days extrinsic incubation. The chimeric MRE1001 cDNA clone should allow identification of viral determinants of midgut infection and dissemination and lead to the development of new SIN virus expression systems.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9527919     DOI: 10.1006/viro.1998.9034

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

Review 1.  Genetics of mosquito vector competence.

Authors:  B T Beerntsen; A A James; B M Christensen
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

Review 2.  Molecular strategies for interrupting arthropod-borne virus transmission by mosquitoes.

Authors:  C D Blair; Z N Adelman; K E Olson
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

3.  Inhibition of luciferase expression in transgenic Aedes aegypti mosquitoes by Sindbis virus expression of antisense luciferase RNA.

Authors:  B W Johnson; K E Olson; T Allen-Miura; A Rayms-Keller; J O Carlson; C J Coates; N Jasinskiene; A A James; B J Beaty; S Higgs
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

4.  The RNA interference pathway affects midgut infection- and escape barriers for Sindbis virus in Aedes aegypti.

Authors:  Cynthia C H Khoo; Joseph Piper; Irma Sanchez-Vargas; Ken E Olson; Alexander W E Franz
Journal:  BMC Microbiol       Date:  2010-04-28       Impact factor: 3.605

5.  Genetic determinants of Sindbis virus mosquito infection are associated with a highly conserved alphavirus and flavivirus envelope sequence.

Authors:  Dennis J Pierro; Erik L Powers; Ken E Olson
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

6.  Deletions in the putative cell receptor-binding domain of Sindbis virus strain MRE16 E2 glycoprotein reduce midgut infectivity in Aedes aegypti.

Authors:  Kevin M Myles; Dennis J Pierro; Ken E Olson
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  LARVAL COMPETITION DIFFERENTIALLY AFFECTS ARBOVIRUS INFECTION IN AEDES MOSQUITOES.

Authors:  Barry W Alto; L Philip Lounibos; Stephen Higgs; Steven A Juliano
Journal:  Ecology       Date:  2005-12       Impact factor: 5.499

8.  Infection of Aedes aegypti Mosquitoes with Midgut-Attenuated Sindbis Virus Reduces, but Does Not Eliminate, Disseminated Infection.

Authors:  Alexis Carpenter; William Bart Bryant; Scott R Santos; Rollie J Clem
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

9.  Gene targeting in mosquito cells: a demonstration of 'knockout' technology in extrachromosomal gene arrays.

Authors:  P Eggleston; Y Zhao
Journal:  BMC Genet       Date:  2001-07-31       Impact factor: 2.797

10.  Characterization of an endogenous gene expressed in Aedes aegypti using an orally infectious recombinant Sindbis virus.

Authors:  L L Cheng; L C Bartholomay; K E Olson; C Lowenberger; J Vizioli; S Higgs; B J Beaty; B M Christensen
Journal:  J Insect Sci       Date:  2001-10-05       Impact factor: 1.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.